These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 16341288)
21. An update on exenatide, a novel therapeutic option for patients with type 2 diabetes. Crasto W; Khunti K; Davies MJ Drugs Today (Barc); 2011 Nov; 47(11):839-56. PubMed ID: 22146227 [TBL] [Abstract][Full Text] [Related]
22. How to fight obesity with antidiabetic drugs: targeting gut or kidney? Baretić M; Troskot R Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984 [TBL] [Abstract][Full Text] [Related]
23. Biological activity of AC3174, a peptide analog of exendin-4. Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977 [TBL] [Abstract][Full Text] [Related]
24. Exenatide: from the Gila monster to the pharmacy. Triplitt C; Chiquette E J Am Pharm Assoc (2003); 2006; 46(1):44-52; quiz 53-5. PubMed ID: 16529340 [TBL] [Abstract][Full Text] [Related]
25. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Meier JJ Nat Rev Endocrinol; 2012 Dec; 8(12):728-42. PubMed ID: 22945360 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes. Molina Vega M; Muñoz-Garach A; Tinahones FJ Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):207-217. PubMed ID: 29260924 [TBL] [Abstract][Full Text] [Related]
27. Clinical implications of exenatide as a twice-daily or once-weekly therapy for type 2 diabetes. Aroda VR; DeYoung MB Postgrad Med; 2011 Sep; 123(5):228-38. PubMed ID: 21904106 [TBL] [Abstract][Full Text] [Related]
29. Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review. Albèr A; Brønden A; Knop FK Diabetes Obes Metab; 2017 Jul; 19(7):915-925. PubMed ID: 28211611 [TBL] [Abstract][Full Text] [Related]
30. Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges. Ghazi T; Rink L; Sherr JL; Herold KC Diabetes Care; 2014; 37(1):210-6. PubMed ID: 23939544 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Kolterman OG; Kim DD; Shen L; Ruggles JA; Nielsen LL; Fineman MS; Baron AD Am J Health Syst Pharm; 2005 Jan; 62(2):173-81. PubMed ID: 15700891 [TBL] [Abstract][Full Text] [Related]
32. Exenatide: a review from pharmacology to clinical practice. Gentilella R; Bianchi C; Rossi A; Rotella CM Diabetes Obes Metab; 2009 Jun; 11(6):544-56. PubMed ID: 19383034 [TBL] [Abstract][Full Text] [Related]
34. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide. van Genugten RE; van Raalte DH; Diamant M Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S26-34. PubMed ID: 20115929 [TBL] [Abstract][Full Text] [Related]
35. Incretins and their role in the management of diabetes. Frias JP; Edelman SV Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):269-76. PubMed ID: 17940451 [TBL] [Abstract][Full Text] [Related]
37. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors. Morales J Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467 [TBL] [Abstract][Full Text] [Related]
38. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Linnebjerg H; Park S; Kothare PA; Trautmann ME; Mace K; Fineman M; Wilding I; Nauck M; Horowitz M Regul Pept; 2008 Nov; 151(1-3):123-9. PubMed ID: 18675854 [TBL] [Abstract][Full Text] [Related]
39. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system. Vergès B; Bonnard C; Renard E Diabetes Metab; 2011 Dec; 37(6):477-88. PubMed ID: 21871831 [TBL] [Abstract][Full Text] [Related]